Public acceptability of COVID-19 vaccines and its predictors in Middle ‎Eastern/North African (MENA) countries: a systematic review‎

Hum Vaccin Immunother. 2022 Nov 30;18(5):2043719. doi: 10.1080/21645515.2022.2043719. Epub 2022 Mar 23.

Abstract

Introduction: COVID-19 vaccines emerged as a worldwide hope to contain the pandemic. However, many people ‎are still hesitant to receive these vaccines. We aimed to systematically review the public knowledge, perception, and acceptability of COVID-19 vaccines in the Middle East and North Africa (MENA) countries and the predictors of vaccine acceptability in this region.

Methods: We systematically searched databases of PubMed, Scopus, Web of Science, and Cochrane and retrieved ‎all relevant studies by 5 August 2021.

Results: There was a considerable variation in the COVID-19 vaccine acceptance ‎rates, from 12% in a study from Israel to 83.3% in Kuwait, although two other studies from Israel mentioned 75% ‎and 82.2% acceptability rates. Concerns about the side effects and safety of the vaccine were the main reasons for ‎the lack of acceptability of taking the vaccine, which was reported in 19 studies. ‎.

Conclusion: Several factors, such as age, gender, education level, and comorbidities, ‎are worthy of attention as they could expand vaccine coverage in the target population.‎.

Keywords: Attitude; COVID-19; COVID-19 vaccine; Middle East; North Africa; SARS-CoV-2; acceptability; perception; vaccine.

Publication types

  • Systematic Review

MeSH terms

  • Africa, Northern / epidemiology
  • COVID-19 Vaccines*
  • COVID-19* / prevention & control
  • Humans
  • Middle East / epidemiology
  • Pandemics

Substances

  • COVID-19 Vaccines

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.